Literature DB >> 18393602

Tenets of protection from progression to AIDS: lessons from the immune responses to HIV-2 infection.

Aleksandra Leligdowicz1, Sarah Rowland-Jones.   

Abstract

In the past 25 years, life survival curves of many countries have been remodeled owing to HIV infection. Both HIV-1 and HIV-2 can cause AIDS, yet patients infected with HIV-2 fare much better clinically and most will never experience detrimental effects of the infection. Despite over two decades of comprehensive research into vaccine development, a prophylactic vaccine is not yet realized. An essential missing link in the innovation of a successful vaccine strategy is the description of a favorable immune response that abolishes virus replication. Lessons learned from studying the role of the immune system in the long-term nonprogression characteristic of HIV-2 infection will offer insight into how a balanced immune response can protect from the destruction of the immune system associated with chronic HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18393602     DOI: 10.1586/14760584.7.3.319

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  7 in total

1.  Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments.

Authors:  Markus Moll; Sofia K Andersson; Anna Smed-Sörensen; Johan K Sandberg
Journal:  Blood       Date:  2010-06-08       Impact factor: 22.113

Review 2.  The quest for a T cell-based immune correlate of protection against HIV: a story of trials and errors.

Authors:  Richard A Koup; Barney S Graham; Daniel C Douek
Journal:  Nat Rev Immunol       Date:  2010-12-17       Impact factor: 53.106

3.  Human immunodeficiency virus type 2 infections in Austria.

Authors:  Ninon Taylor; Jan Marco Kern; Wolfgang Prammer; Alois Lang; Bernhard Haas; Martin Gisinger; Robert Zangerle; Alexander Egle; Richard Greil; Hannes Oberkofler; Josef Eberle
Journal:  Wien Klin Wochenschr       Date:  2014-01-18       Impact factor: 1.704

4.  Potent and broadly reactive HIV-2 neutralizing antibodies elicited by a vaccinia virus vector prime-C2V3C3 polypeptide boost immunization strategy.

Authors:  José Maria Marcelino; Pedro Borrego; Cheila Rocha; Helena Barroso; Alexandre Quintas; Carlos Novo; Nuno Taveira
Journal:  J Virol       Date:  2010-09-15       Impact factor: 5.103

5.  Changes in the level of apoptosis-related proteins in Jurkat cells infected with HIV-1 versus HIV-2.

Authors:  Xue Wang; Ragupathy Viswanath; Jiangqin Zhao; Shixing Tang; Indira Hewlett
Journal:  Mol Cell Biochem       Date:  2009-10-20       Impact factor: 3.396

Review 6.  Viral factors in non-progression.

Authors:  Bin Wang
Journal:  Front Immunol       Date:  2013-12-24       Impact factor: 7.561

7.  Sang Froid in a time of trouble: is a vaccine against HIV possible?

Authors:  Stanley A Plotkin
Journal:  J Int AIDS Soc       Date:  2009-02-02       Impact factor: 5.396

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.